Constellation Pharmaceuticals
Clinical trials sponsored by Constellation Pharmaceuticals, explained in plain language.
-
New combo therapy shows promise for Hard-to-Treat prostate cancer
Disease control CompletedThis study tested a new oral drug (CPI-1205) combined with standard hormone-blocking treatments (enzalutamide or abiraterone/prednisone) in 175 men with metastatic castration-resistant prostate cancer (mCRPC). The goal was to find the safest dose and see if the combination works …
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
New drug combo shows promise for rare blood cancers
Disease control CompletedThis study tested a new pill called pelabresib in people with certain blood cancers, including myelofibrosis and leukemia. The goal was to see if it could shrink enlarged spleens and reduce the need for blood transfusions. The drug was given alone or with another medicine (ruxoli…
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated May 08, 2026 12:01 UTC